A detailed history of Walleye Trading LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Walleye Trading LLC holds 22,900 shares of AVXL stock, worth $124,576. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,900
Previous 30,200 24.17%
Holding current value
$124,576
Previous $153,000 37.25%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$5.04 - $9.95 $103,183 - $203,706
20,473 New
20,473 $190,000
Q2 2022

Aug 08, 2022

BUY
$7.31 - $12.84 $209,650 - $368,251
28,680 New
28,680 $287,000
Q4 2021

Feb 14, 2022

SELL
$16.88 - $23.31 $2,396 - $3,310
-142 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$16.82 - $25.75 $1.03 Million - $1.57 Million
-60,999 Reduced 99.77%
142 $3,000
Q2 2021

Aug 16, 2021

BUY
$10.16 - $28.86 $621,192 - $1.76 Million
61,141 New
61,141 $1.4 Million

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $424M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.